The digitalization of the healthcare ecosystem is also driving the digitalization of therapies. Digital Therapeutics (DTx) is not new, and they were already talked about as evidence-based clinical interventions that are delivered digitally. DTx is considered one of the most innovative areas within digital health and is forecasted to grow fivefold in the next three to five years.
The majority of DTx are targeting therapies for chronic diseases and neurological/psychiatric disorders. However, some challenges need to be addressed concerning the complexity and slowness of regulatory processes, reimbursement policies, stakeholder awareness & adoption, and narrowly . . .
Access the full-content and exclusive insights by registering to futurebridge.com.
Stay on top of your industry related trends and oppotunities.
Get insightful information access without any restrictions.
Learn about fundamental challenges confronted by your industry.
Gain access to all upcoming webinars and reply on-demand.
Share your focus area or question to engage with our Analysts through the Business Objectives service.
Submit My Business ObjectiveOur long-standing clients include some of the worlds leading brands and forward-thinking corporations.